In Vitro Diagnostics (IVD) Quality Control Global Market Report 2026

Description

In-vitro diagnostics (IVD) quality control encompasses a set of processes designed to ensure the accuracy, performance, and environmental conditions impacting in vitro diagnostic tests, including in vitro nucleic acid testing processes for pathogen detection and healthcare-associated infections (HAIs) like pneumonia and urinary tract infections.

The primary products in in-vitro diagnostics quality control include quality control products, data management solutions, and quality assurance services. Quality control products comprise serum/plasma-based control products, whole blood-based control products, urine-based control products, and other control products manufactured by IVD instrument manufacturers. These products aim to cure, mitigate, or treat conditions through in-vitro diagnostics quality control. Manufacturers can be categorized as IVD instrument manufacturers and third-party quality control manufacturers. These products find applications in various diagnostic areas, such as clinical chemistry, hematology, immunoassay, molecular diagnostics, microbiology, coagulation, or hemostasis, among others. The implementation of in-vitro diagnostics quality control occurs in various settings, including hospitals, clinical laboratories, research and academic institutes, and other healthcare facilities.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Tariffs are impacting the in vitro diagnostics quality control market by increasing the costs of control materials, software platforms, and quality assurance kits that depend on cross border manufacturing and sourcing. These effects are particularly evident in molecular diagnostics, immunoassay, and clinical chemistry segments, as well as in regions where IVD imports form a major share of supply such as Asia Pacific and Europe. However, tariffs are also encouraging localization of IVD quality control production and regional manufacturing investments, supporting domestic capability building. Overall, tariffs are reshaping procurement strategies while pushing stakeholders toward supply diversification and cost optimization initiatives.

The in vitro diagnostics (ivd) quality control market research report is one of a series of new reports from The Business Research Company that provides in vitro diagnostics (ivd) quality control market statistics, including in vitro diagnostics (ivd) quality control industry global market size, regional shares, competitors with a in vitro diagnostics (ivd) quality control market share, detailed in vitro diagnostics (ivd) quality control market segments, market trends and opportunities, and any further data you may need to thrive in the in vitro diagnostics (ivd) quality control industry. This in vitro diagnostics (ivd) quality control market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The in vitro diagnostics (ivd) quality control market size has grown strongly in recent years. It will grow from $1.48 billion in 2025 to $1.61 billion in 2026 at a compound annual growth rate (CAGR) of 8.5%. The growth in the historic period can be attributed to growing burden of infectious diseases, rising adoption of in vitro diagnostic devices, regulatory focus on diagnostic accuracy, expansion of clinical laboratory networks, increasing awareness of testing quality standards.

The in vitro diagnostics (ivd) quality control market size is expected to see strong growth in the next few years. It will grow to $2.24 billion in 2030 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to rising demand for molecular diagnostics precision, increasing healthcare digitalization, growing adoption of automated lab systems, expanding healthcare infrastructure investments, stricter regulatory compliance requirements. Major trends in the forecast period include increasing emphasis on diagnostic accuracy and reliability, rising focus on quality compliance and standardization, growing adoption of external quality assessment programs, expansion of multiplex and molecular diagnostic testing validation, increasing use of automated quality monitoring systems.

The rising prevalence of infectious diseases is expected to propel the growth of the in vitro diagnostics (IVD) quality control market going forward. Infectious diseases are illnesses caused by pathogenic microorganisms such as bacteria, viruses, fungi, or parasites that can spread directly or indirectly between individuals. The prevalence of infectious diseases is increasing due to factors such as growing antimicrobial resistance, which makes common infections more difficult to treat and control, thereby facilitating wider transmission. IVD quality control plays a critical role in ensuring the accuracy, reliability, and consistency of diagnostic test results, enabling timely detection of infectious pathogens and supporting effective clinical decision-making and patient management. For instance, in October 2024, according to the World Health Organization (WHO), a Switzerland-based international public health organization, approximately 8.2 million people were newly diagnosed with tuberculosis in 2023, an increase from about 7.5 million in 2022, making tuberculosis the leading infectious disease killer globally. Therefore, the rising prevalence of infectious diseases is driving the growth of the in vitro diagnostics (IVD) quality control market.

Major companies operating in the in vitro diagnostics (IVD) quality control market are focusing on integrating advanced technologies such as embedded barcode-scanning systems to improve efficiency, streamline diagnostic workflows, and reduce processing errors. Embedded barcode-scanning systems are compact fixed-mount devices and smart vision modules that automatically read barcodes and capture data in real time, enabling accurate specimen identification, automated data entry, and enhanced traceability throughout the diagnostic process. For instance, in November 2023, Newland EMEA, a Netherlands-based digital technology company, launched a new line of IVD-focused barcode-scanning products at the MEDICA trade fair. The portfolio includes high-speed scanners such as the FM510 and FM530, the versatile FM550, and the smart FM600 camera, all designed to enhance automation, improve diagnostic speed, and increase accuracy in IVD laboratories. This launch highlights the growing emphasis on automation and data integrity in diagnostic quality control.

In May 2024, Bruker, a US-based analytical instrumentation company, acquired ELITechGroup for €870 ($948) million. This acquisition aims to strengthen Bruker's position in the molecular diagnostics market by integrating ELITech's innovative sample-to-answer platforms along with its diverse portfolio of assays for infectious diseases. ELITech, also a US-based in-vitro diagnostics company, develops, manufactures, and markets a wide range of advanced diagnostic products and solutions, which include instruments, reagents, and software.

Major companies operating in the in vitro diagnostics (ivd) quality control market report are Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., LGC Limited., Abbott Laboratories, Roche Diagnostics AG, Siemens AG, Ortho Clinical Diagnostics Inc., Helena Laboratories Corporation, Quidel Corporation, Microbiologics Inc., Sun Diagnostics LLC, Fortress Diagnostics Ltd., Seegene Inc., Bio-Techne Corp., Randox Laboratories, Danaher Corporation, Sysmex Corporation, Beckman Coulter Inc., Grifols India Healthcare Private Limited., Hologic Inc., Qiagen NV, Becton Dickinson and Company, Luminex Corporation, BioMerieux SA, Meridian Bioscience Inc., Sekisui Diagnostics LLC, ZeptoMetrix Corporation, Maine Molecular Quality Controls Inc.

North America was the largest region in the in vitro diagnostics (IVD) quality control market in 2025.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the in vitro diagnostics (ivd) quality control market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the in vitro diagnostics (ivd) quality control market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The in-vitro diagnostics (IVD) quality control market consists of revenues earned by entities that evaluate and validate the reliability of in-vitro diagnostics testing systems. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

In Vitro Diagnostics (IVD) Quality Control Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses in vitro diagnostics (ivd) quality control market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on end user analysis.
Benchmark performance against key competitors based on market share, innovation, and brand strength.
Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for in vitro diagnostics (ivd) quality control ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The in vitro diagnostics (ivd) quality control market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

Markets Covered:1) By Product type: Quality Control Products; Data Management Solutions; Quality Assurance Services
2) By Manufacturer Type: IVD Instrument Manufacturers; Third Party Quality Control Manufacturers
3) By Application: Clinical Chemistry; Hematology; Immunoassay; Molecular Diagnostics; Microbiology; Coagulation Or Hemostasis; Other Applications
4) By End-Users: Hospitals; Clinical Laboratories; Research And Academic Institutes; Other End Users
Subsegments:
1) By Quality Control Products: Control Materials; Quality Control Kits; Proficiency Testing Samples
2) By Data Management Solutions: Software For Quality Control Management; Data Analysis Tools; Cloud-Based Solutions
3) By Quality Assurance Services: Consulting Services; Training And Education Services; Audit And Compliance Services
Companies Mentioned: Bio-Rad Laboratories Inc.; Thermo Fisher Scientific Inc.; LGC Limited.; Abbott Laboratories; Roche Diagnostics AG; Siemens AG; Ortho Clinical Diagnostics Inc.; Helena Laboratories Corporation; Quidel Corporation; Microbiologics Inc.; Sun Diagnostics LLC; Fortress Diagnostics Ltd.; Seegene Inc.; Bio-Techne Corp.; Randox Laboratories; Danaher Corporation; Sysmex Corporation; Beckman Coulter Inc.; Grifols India Healthcare Private Limited.; Hologic Inc.; Qiagen NV; Becton Dickinson and Company; Luminex Corporation; BioMerieux SA; Meridian Bioscience Inc.; Sekisui Diagnostics LLC; ZeptoMetrix Corporation; Maine Molecular Quality Controls Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report
+ Excel Dashboard
Added Benefits
Bi-Annual Data Update
Customisation
Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Product Code: SE3MIVDI01_G26Q1

1. Executive Summary

1.1. Key Market Insights (2020-2035)
1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
1.3. Major Factors Driving the Market
1.4. Top Three Trends Shaping the Market

2. In Vitro Diagnostics (IVD) Quality Control Market Characteristics

2.1. Market Definition & Scope
2.2. Market Segmentations
2.3. Overview of Key Products and Services
2.4. Global In Vitro Diagnostics (IVD) Quality Control Market Attractiveness Scoring And Analysis
- 2.4.1. Overview of Market Attractiveness Framework
- 2.4.2. Quantitative Scoring Methodology
- 2.4.3. Factor-Wise Evaluation
Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation
2.4.5. Strategic Implications and Recommendations

3. In Vitro Diagnostics (IVD) Quality Control Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem
3.2. List Of Key Raw Materials, Resources & Suppliers
3.3. List Of Major Distributors and Channel Partners
3.4. List Of Major End Users

4. Global In Vitro Diagnostics (IVD) Quality Control Market Trends And Strategies

4.1. Key Technologies & Future Trends
- 4.1.1 Biotechnology, Genomics & Precision Medicine
- 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
- 4.1.3 Artificial Intelligence & Autonomous Intelligence
- 4.1.4 Industry 4.0 & Intelligent Manufacturing
- 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
4.2. Major Trends
- 4.2.1 Increasing Emphasis On Diagnostic Accuracy And Reliability
- 4.2.2 Rising Focus On Quality Compliance And Standardization
- 4.2.3 Growing Adoption Of External Quality Assessment Programs
- 4.2.4 Expansion Of Multiplex And Molecular Diagnostic Testing Validation
- 4.2.5 Increasing Use Of Automated Quality Monitoring Systems

5. In Vitro Diagnostics (IVD) Quality Control Market Analysis Of End Use Industries

5.1 Hospitals
5.2 Clinical Laboratories
5.3 Diagnostic Centers
5.4 Research And Academic Institutes
5.5 Reference Laboratories

6. In Vitro Diagnostics (IVD) Quality Control Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global In Vitro Diagnostics (IVD) Quality Control Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global In Vitro Diagnostics (IVD) Quality Control PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
7.2. Global In Vitro Diagnostics (IVD) Quality Control Market Size, Comparisons And Growth Rate Analysis
7.3. Global In Vitro Diagnostics (IVD) Quality Control Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
7.4. Global In Vitro Diagnostics (IVD) Quality Control Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global In Vitro Diagnostics (IVD) Quality Control Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)
8.2. Methodology and Assumptions
8.3. Global Total Addressable Market (TAM) Estimation
8.4. TAM vs. Current Market Size Analysis
8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. In Vitro Diagnostics (IVD) Quality Control Market Segmentation

9.1. Global In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Product type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Quality Control Products, Data Management Solutions, Quality Assurance Services
9.2. Global In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Manufacturer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
IVD Instrument Manufacturers, Third Party Quality Control Manufacturers
9.3. Global In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Clinical Chemistry, Hematology, Immunoassay, Molecular Diagnostics, Microbiology, Coagulation Or Hemostasis, Other Applications
9.4. Global In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Hospitals, Clinical Laboratories, Research And Academic Institutes, Other End Users
9.5. Global In Vitro Diagnostics (IVD) Quality Control Market, Sub-Segmentation Of Quality Control Products, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Control Materials, Quality Control Kits, Proficiency Testing Samples
9.6. Global In Vitro Diagnostics (IVD) Quality Control Market, Sub-Segmentation Of Data Management Solutions, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Software For Quality Control Management, Data Analysis Tools, Cloud-Based Solutions
9.7. Global In Vitro Diagnostics (IVD) Quality Control Market, Sub-Segmentation Of Quality Assurance Services, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Consulting Services, Training And Education Services, Audit And Compliance Services

10. In Vitro Diagnostics (IVD) Quality Control Market Regional And Country Analysis

10.1. Global In Vitro Diagnostics (IVD) Quality Control Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
10.2. Global In Vitro Diagnostics (IVD) Quality Control Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific In Vitro Diagnostics (IVD) Quality Control Market

11.1. Asia-Pacific In Vitro Diagnostics (IVD) Quality Control Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Product type, Segmentation By Manufacturer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China In Vitro Diagnostics (IVD) Quality Control Market

12.1. China In Vitro Diagnostics (IVD) Quality Control Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
12.2. China In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Product type, Segmentation By Manufacturer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India In Vitro Diagnostics (IVD) Quality Control Market

13.1. India In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Product type, Segmentation By Manufacturer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan In Vitro Diagnostics (IVD) Quality Control Market

14.1. Japan In Vitro Diagnostics (IVD) Quality Control Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
14.2. Japan In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Product type, Segmentation By Manufacturer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia In Vitro Diagnostics (IVD) Quality Control Market

15.1. Australia In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Product type, Segmentation By Manufacturer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia In Vitro Diagnostics (IVD) Quality Control Market

16.1. Indonesia In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Product type, Segmentation By Manufacturer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea In Vitro Diagnostics (IVD) Quality Control Market

17.1. South Korea In Vitro Diagnostics (IVD) Quality Control Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
17.2. South Korea In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Product type, Segmentation By Manufacturer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan In Vitro Diagnostics (IVD) Quality Control Market

18.1. Taiwan In Vitro Diagnostics (IVD) Quality Control Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
18.2. Taiwan In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Product type, Segmentation By Manufacturer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia In Vitro Diagnostics (IVD) Quality Control Market

19.1. South East Asia In Vitro Diagnostics (IVD) Quality Control Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
19.2. South East Asia In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Product type, Segmentation By Manufacturer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe In Vitro Diagnostics (IVD) Quality Control Market

20.1. Western Europe In Vitro Diagnostics (IVD) Quality Control Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
20.2. Western Europe In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Product type, Segmentation By Manufacturer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK In Vitro Diagnostics (IVD) Quality Control Market

21.1. UK In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Product type, Segmentation By Manufacturer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany In Vitro Diagnostics (IVD) Quality Control Market

22.1. Germany In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Product type, Segmentation By Manufacturer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France In Vitro Diagnostics (IVD) Quality Control Market

23.1. France In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Product type, Segmentation By Manufacturer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy In Vitro Diagnostics (IVD) Quality Control Market

24.1. Italy In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Product type, Segmentation By Manufacturer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain In Vitro Diagnostics (IVD) Quality Control Market

25.1. Spain In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Product type, Segmentation By Manufacturer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe In Vitro Diagnostics (IVD) Quality Control Market

26.1. Eastern Europe In Vitro Diagnostics (IVD) Quality Control Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
26.2. Eastern Europe In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Product type, Segmentation By Manufacturer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia In Vitro Diagnostics (IVD) Quality Control Market

27.1. Russia In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Product type, Segmentation By Manufacturer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America In Vitro Diagnostics (IVD) Quality Control Market

28.1. North America In Vitro Diagnostics (IVD) Quality Control Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
28.2. North America In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Product type, Segmentation By Manufacturer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA In Vitro Diagnostics (IVD) Quality Control Market

29.1. USA In Vitro Diagnostics (IVD) Quality Control Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
29.2. USA In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Product type, Segmentation By Manufacturer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada In Vitro Diagnostics (IVD) Quality Control Market

30.1. Canada In Vitro Diagnostics (IVD) Quality Control Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
30.2. Canada In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Product type, Segmentation By Manufacturer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America In Vitro Diagnostics (IVD) Quality Control Market

31.1. South America In Vitro Diagnostics (IVD) Quality Control Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
31.2. South America In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Product type, Segmentation By Manufacturer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil In Vitro Diagnostics (IVD) Quality Control Market

32.1. Brazil In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Product type, Segmentation By Manufacturer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East In Vitro Diagnostics (IVD) Quality Control Market

33.1. Middle East In Vitro Diagnostics (IVD) Quality Control Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
33.2. Middle East In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Product type, Segmentation By Manufacturer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa In Vitro Diagnostics (IVD) Quality Control Market

34.1. Africa In Vitro Diagnostics (IVD) Quality Control Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
34.2. Africa In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Product type, Segmentation By Manufacturer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. In Vitro Diagnostics (IVD) Quality Control Market Regulatory and Investment Landscape

36. In Vitro Diagnostics (IVD) Quality Control Market Competitive Landscape And Company Profiles

36.1. In Vitro Diagnostics (IVD) Quality Control Market Competitive Landscape And Market Share 2024
- 36.1.1. Top 10 Companies (Ranked by revenue/share)
36.2. In Vitro Diagnostics (IVD) Quality Control Market - Company Scoring Matrix
- 36.2.1. Market Revenues
- 36.2.2. Product Innovation Score
- 36.2.3. Brand Recognition
36.3. In Vitro Diagnostics (IVD) Quality Control Market Company Profiles
- 36.3.1. Bio-Rad Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis
- 36.3.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
- 36.3.3. LGC Limited. Overview, Products and Services, Strategy and Financial Analysis
- 36.3.4. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
- 36.3.5. Roche Diagnostics AG Overview, Products and Services, Strategy and Financial Analysis

37. In Vitro Diagnostics (IVD) Quality Control Market Other Major And Innovative Companies

Siemens AG, Ortho Clinical Diagnostics Inc., Helena Laboratories Corporation, Quidel Corporation, Microbiologics Inc., Sun Diagnostics LLC, Fortress Diagnostics Ltd., Seegene Inc., Bio-Techne Corp., Randox Laboratories, Danaher Corporation, Sysmex Corporation, Beckman Coulter Inc., Grifols India Healthcare Private Limited., Hologic Inc.

38. Global In Vitro Diagnostics (IVD) Quality Control Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The In Vitro Diagnostics (IVD) Quality Control Market

40. In Vitro Diagnostics (IVD) Quality Control Market High Potential Countries, Segments and Strategies

40.1 In Vitro Diagnostics (IVD) Quality Control Market In 2030 - Countries Offering Most New Opportunities
40.2 In Vitro Diagnostics (IVD) Quality Control Market In 2030 - Segments Offering Most New Opportunities
40.3 In Vitro Diagnostics (IVD) Quality Control Market In 2030 - Growth Strategies
- 40.3.1 Market Trend Based Strategies
- 40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations
41.2. Currencies
41.3. Historic And Forecast Inflation Rates
41.4. Research Inquiries
41.5. The Business Research Company
41.6. Copyright And Disclaimer